Articles tagged with 'Neuro' | Cedars-Sinai Medical Center

Two new publications from Cedars-Sinai neuroscientists are helping to advance scientific understanding of the complex molecular and cellular processes involved in Alzheimer’s disease—and the body’s innate immune mechanisms for fighting against the co...

A Cedars-Sinai study has identified a group of brain cells in laboratory mice that regulate stress-induced feeding and calorie expenditure, with a more pronounced effect in females than in males.The discovery, published in the peer-reviewed journal N...

In July, the first direct-to-consumer blood test designed to assess a user’s risk for developing Alzheimer’s disease hit the market. The test, which has not undergone Food and Drug Administration (FDA) review, measures the level of a protein called b...

Donnè Ward, a Mira Costa High School sophomore, has always been interested in medicine. So interested that his grandmother, Trena Lawson, said he was 5 when he first talked about becoming a doctor.  As a member of the Los Angeles Clippers Mentorship ...

Cedars-Sinai patient care teams are preparing to offer lecanemab, a new Alzheimer’s disease treatment that has received approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.  “This is the most promising therapy ...

Building on its visionary investment in Cedars-Sinai’s neurosurgery scholarship program, The Ray Charles Foundation has donated a second gift of $1 million to support critical training and research to advance the neurosciences.The Ray Charles Foundat...

Blood vessel abnormalities in the eye are a major factor in the progression of Alzheimer’s disease, according to research from Cedars-Sinai investigators published in the peer-reviewed journal Alzheimer's & Dementia: The Journal of the Alzheimer's As...

Investigators at Cedars-Sinai have created computer-generated models to bridge the gap between “test tube” data about neurons and the function of those cells in the living brain. Their study, published in the peer-reviewed journal Nature Communicatio...

The first prospective study comparing outcomes in patients with pituitary apoplexy—sudden bleeding or death of a pituitary tumor—found that patients managed medically fared as well as those treated surgically in the majority of cases. The multicenter...

A new study by Cedars-Sinai investigators found that people whose blood pressure fluctuated while they were in the hospital were at greater risk for developing Alzheimer’s disease or other types of dementia than people whose blood pressure remained s...

The Departments of Neurology and Neurosurgery at Cedars-Sinai highlighted progress against Alzheimer’s disease, Parkinson’s disease, ALS, multiple sclerosis, brain cancer and stroke in their 2023 Annual Report, which also details advancements in spin...

Cedars-Sinai has received a gift of more than $140 million—the largest gift in the hospital’s 121-year history—from the estate of longtime supporters Susanne and Ervin Bard. This gift will propel clinical and research innovation in the medical campus...

New research published by investigators at Cedars-Sinai advances scientific understanding of how the brain weighs decisions involving what people like or value, such as choosing which book to read, which restaurant to pick for lunch—or even, which sl...

Cedars-Sinai and its affiliate Huntington Health are collaborating on a new Epilepsy Monitoring Unit to bring treatment and care closer to epilepsy patients in the San Gabriel Valley.Epilepsy causes intense bursts of electrical activity in the brain,...

Cedars-Sinai investigators have produced the most extensive analysis to date of changes in the retina—a layer of tissue at the back of the eye where visual information originates—and how those retinal changes correspond to brain and cognitive changes...

Every day for six weeks, Neil Wank, a 26-year Los Angeles Police Department veteran who in December was diagnosed with an aggressive type of brain cancer called glioblastoma, was escorted down the long hallway leading to the Cedars-Sinai Cancer radia...

A new study led by Cedars-Sinai investigators identified a marker in the brain that controls the ability to reach and grasp, a fundamental fine motor skill that is often impaired in motor or neural injuries such as a stroke.The findings, published in...

A new Cedars-Sinai study in collaboration with the University of California, Irvine (UCI) and the Answer ALS consortium has examined the expression of thousands of genes in stem cell generated motor neurons that are known to die in patients with amyo...

Many think of epilepsy, a neurological disorder affecting 3.4 million Americans, as a chronic condition marked by occasional seizures. But the disease can be deadly, so it is essential for patients to get their seizures under control with proper trea...

A new Cedars-Sinai study suggests that some patients diagnosed with behavioral-variant frontotemporal dementia (bvFTD)—an incurable condition that robs patients of the ability to control their behavior and cope with daily living—may instead have a ce...

The U.S. Food and Drug Administration (FDA) recently granted approval to lecanemab, the first Alzheimer’s disease treatment to win approval since the largely failed rollout of Aduhelm two years ago. Sold under the brand name Leqembi, the new drug sho...

Cedars-Sinai neuroscientists, using data from human brain tissue, have created ultrarealistic computational models of epileptic brain circuits, allowing them to probe the cause and effect of genetic and other factors and suggesting new therapeutic po...

Delirium is common among women with urinary tract infections (UTIs)—especially those who have experienced menopause. Investigators from Cedars-Sinai, working with laboratory mice, have been able to prevent symptoms of the condition with estrogen, whi...

Ahead of World Stroke Day, Oct. 29, investigators from the Department of Neurology at Cedars-Sinai have new information on stroke-related health disparities. In a study published in the peer-reviewed journal Scientific Reports, they determined that o...

Investigators from the Cedars-Sinai Department of Neurosurgery have identified for the first time a new subtype of immune cell in the retina that is linked to changes—such as inflammation and amyloid deposits—caused by Alzheimer’s disease. By reducin...

Investigators from the departments of Neurology, Neurosurgery, Psychiatry, Medicine, and Biomedical Sciences at Cedars-Sinai have shown that an immune-suppressing drug similar to one used to treat severe COVID-19 reversed symptoms of delirium in mice...

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor neur...

Sheri Saenz is enjoying everyday pleasures as a Laguna Niguel grandmother, crafting and camping with her granddaughter and grandson and vacationing with her husband of 34 years.But 30 years ago, in 1992, Saenz received a brain cancer diagnosis that m...

Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk—but that severe COVID-19 infection does. Physician-scientists hope this gr...

Cedars-Sinai investigators have created bio-realistic and complex computer models of individual brain cells—in unparalleled quantity. Their research, published today in the peer-reviewed journal Cell Reports, details how these models could one day an...